Date published: 2025-12-22

001 800-1338-3838

SCBT Portrait Logo
Seach Input

LTBP-2阻害剤

LTBP-2 inhibitors are a specialized class of compounds designed to target and inhibit the activity of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP-2). LTBP-2 is a member of the LTBP family of proteins that play a critical role in the regulation of transforming growth factor-beta (TGF-β) signaling, a key pathway involved in cellular growth, differentiation, and extracellular matrix (ECM) formation. Unlike other members of the LTBP family, LTBP-2 does not directly bind to TGF-β but instead interacts with the ECM and other structural components within the cellular environment. Inhibiting LTBP-2 offers researchers a unique tool to study its distinct role in ECM organization, the modulation of cell-matrix interactions, and its broader impact on cell signaling pathways.

The use of LTBP-2 inhibitors in scientific research is particularly valuable for exploring the non-TGF-β related functions of this protein, which are less understood compared to other LTBP family members. By inhibiting LTBP-2, researchers can disrupt its interactions within the ECM, allowing for a closer examination of how these interactions influence tissue architecture, cell adhesion, and mechanical signaling within various cellular contexts. Additionally, LTBP-2 inhibitors help to unravel the complexities of ECM dynamics, shedding light on how alterations in ECM composition and structure can affect cellular behavior and tissue integrity. This class of inhibitors is essential for advancing our understanding of ECM biology, providing insights into the intricate networks that maintain cellular and tissue homeostasis. Through the study of LTBP-2 inhibitors, researchers can gain a deeper appreciation of the multifaceted roles that ECM components play in regulating cell function and the overall maintenance of cellular environments.

関連項目

製品名CAS #カタログ #数量価格引用文献レーティング

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

TGF-β経路を標的とすることで、潜在的な形質転換増殖因子β結合タンパク質(LTBP)に間接的に影響する可能性がある。

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$105.00
$153.00
4
(1)

別のTGF-β阻害剤も、潜在的な形質転換増殖因子β結合タンパク質(LTBP)に間接的に影響する可能性がある。

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$165.00
$214.00
$396.00
$617.00
$4804.00
19
(1)

別のMMP阻害剤も、潜在的な形質転換増殖因子β結合タンパク質(LTBP)に間接的に影響する可能性がある。

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

PI3K/Akt/mTOR阻害剤;間接的に潜在性形質転換成長因子β結合タンパク質(LTBP)を調節する可能性がある。

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

別のPI3K/Akt/mTOR阻害剤;間接的に潜在性形質転換成長因子β結合タンパク質(LTBP)に影響を与える可能性がある。

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

mTORを標的とし、それにより間接的に潜在性形質転換成長因子β結合タンパク質(LTBP)を調節する可能性がある。

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

別のEGFR阻害剤であり、潜在性形質転換成長因子β結合タンパク質(LTBP)にも間接的に影響する可能性がある。

Halofuginone

55837-20-2sc-507290
100 mg
$1740.00
(0)

Smad3阻害剤であり、Smad依存性シグナル伝達を介して潜在性形質転換成長因子β結合タンパク質(LTBP)に間接的に影響する可能性がある。